UBS O'Connor’s Alkermes ALKS Stock Holding History

UBS O'Connor’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-25,000	Closed	-$58.1K	–	282
2025 Q2	$58.1K	Buy	+25,000	New	+$744K	﹤0.01%	325

Other funds holding ALKS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

UBS O'Connor's ALKS Position: Q1 2025 in Review

UBS O'Connor sold out of Alkermes (ALKS) in Q1 2025, closing a stake of 9,710 shares — an estimated $279K sold.

UBS O'Connor first reported a position in ALKS in Q4 2023 and held it in 4 quarters. The position peaked at $1.86M in Q2 2024. 371 funds tracked by Wall St. Rank hold ALKS as of Q1 2025.

UBS O'Connor reported no remaining Alkermes position as of Q1 2025 after selling out during the quarter.
UBS O'Connor sold 9,710 Alkermes shares in Q1 2025, an estimated $279K.
UBS O'Connor first reported a position in Alkermes in Q4 2023 and held it in 4 quarters.
UBS O'Connor's Alkermes position peaked at $1.86M in Q2 2024.
371 funds tracked by Wall St. Rank held Alkermes as of Q1 2025.

Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.